- No public price. The site shows no plan, billing period or trial.
- Not disclosed
- Not disclosed
- —
- —
- US
Radiology
Riverain ClearRead
by Riverain · US
ClearRead finds lung nodules on chest CT and X-ray, scores coronary calcium on CT and flags pneumothorax on X-ray.
On this page
21/100Niche fit
- Regulatory & Compliance18/28
FDA cleared (8 K-numbers on record)
- Clinical Integration0/26
No EHR integrations listed
- Evidence Strength0/26
No peer-reviewed coverage
- Vendor & Market3/18
Seed-stage or unfunded
- Sentiment & Transparency2.5/14
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance18/18
FDA cleared (8 K-numbers on record)
- HIPAA / SOC2 / BAA0/10
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/14
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/8
None of the top-3 EHRs covered
- Bidirectional write-back0/4
No bidirectional write-back documented
- Peer-reviewed papers0/18
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/8
No RCT, meta-analysis, or systematic review
- Funding & adoption signal3/12
Seed-stage or unfunded
- Years in market0/6
Founded year not recorded
- Clinician sentiment (Reddit)0/9
No clinician sentiment data available
- Pricing transparency3/5
Pricing on request, no public amounts
ClearRead finds lung nodules on chest CT and X-ray, scores coronary calcium on CT and flags pneumothorax on X-ray.
No public price. The site shows no plan, billing period or trial.
Bottom line
ClearRead is Riverain Technologies' chest imaging software, sold as ClearRead CT (pulmonary nodule detection and coronary artery calcification scoring) and ClearRead Xray (nodule detection, pneumothorax detection and bone suppression). Riverain's FDA 510(k) clearances reach back to 2007, and the newest, for CAC scoring on CT, dates from December 2024. The software fits radiology groups and hospitals that read chest CT and chest X-ray in volume.
Who is Riverain and what does ClearRead do?
Riverain is based in Miamisburg, Ohio, and was founded in 2004 as Riverain Medical, according to its 2019 funding announcement. That announcement describes a $15 million growth investment in September 2019, led by Ping An Global Voyager Fund. Riverain describes itself as a maker of AI tools for cardiothoracic imaging and claims more than 400 customer locations worldwide.
On CT, ClearRead looks for pulmonary nodules and scores coronary artery calcification on routine chest scans. Riverain's site points to Medicare code G0680 as the reimbursement route for AI-based CAC scoring on routine chest CT. On X-ray, the software flags nodules and pneumothorax and offers bone suppression.
A footnote on Riverain's site labels ClearRead CT LTA as research use only.
Which FDA clearances does Riverain hold?
FDA's 510(k) database lists eight Riverain clearances. Five sit under the Riverain Technologies name:
- K242188, December 2024, ClearRead CT CAC
- K221612, December 2022, ClearRead CT
- K213566, March 2022, ClearRead Xray Pneumothorax
- K161201, September 2016, ClearRead CT
- K123526, December 2012, ClearRead +Confirm
The other three are DeltaView (K111776, December 2011, filed by Riverain Medical Group), SoftView (K092363, March 2010) and FirstView (K071492, August 2007).
Is there a public price?
Riverain publishes no price. What it charges by, whether scan, site or modality, is not public either.
How is it deployed, and what does Riverain say about security?
A Riverain Business Wire release describes the software as available on premises or in the cloud. Riverain's product pages do not mention HIPAA, SOC 2 or HITRUST. The site quotes one unnamed physician on detection rate and reading time.
The verdict
Radiology groups that read chest CT and chest X-ray in volume have the most to evaluate. The December 2024 CAC clearance comes with the G0680 billing route Riverain describes, and the March 2022 clearance covers pneumothorax on X-ray. A group whose work is mostly other body regions gains little from a cardiothoracic product, and a buyer who needs a public price or a security attestation before a first call gets neither from Riverain.
Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Quote only | — | — | No public price. The site shows no plan, billing period or trial. |
Source: vendor pricing page. Last checked October 15, 2026.
What deploys cleanly
Carries FDA 510(k) per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.
Other radiology
See the full radiology ranking
Siemens Healthineers AI-Rad Companion
by Siemens Healthineers
AI-Rad Companion: Chest CT, Chest X-ray, Brain MR, Prostate MR and Organs RT (radiotherapy contouring) modules, delivered through teamplay.
No public price on the vendor page.|FDA 510(k) (multiple) / CE Mark (MDD/MDR. MDR status not verified)
GE HealthCare AI Suite
by GE HealthCare
Portfolio of separately cleared AI-enabled GE HealthCare devices and software, including AIR Recon DL, Sonic DL, Critical Care Suite, Caption AI and icobrain.
No public price. Products are sold with scanners or as scanner options, on enterprise quotes.|FDA 510(k) (multiple)
Aidoc
by Aidoc
Clinical AI platform (aiOS) with FDA-cleared triage, notification and quantification algorithms for radiology and neurovascular care.
Private offer only. No trial is stated.|FDA 510(k) (multiple) / EU MDR 2017/745
Viz.ai
by Viz.ai
Care coordination platform with FDA-cleared imaging AI for stroke, vascular and cardiac conditions.
No public price. Sold to health systems after a demo request.|FDA 510(k) (multiple) / FDA De Novo (ContaCT, Viz HCM)